Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transabdominal Ultrasound With BR55 for Characterization of Pancreatic Lesions

NCT03486327 is registered in ClinicalTrials.gov with Bracco Diagnostics, Inc as lead sponsor.

NCT NCT03486327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03486327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transabdominal Ultrasound With BR55 for Characterization of Pancreatic Lesions
Lead sponsor
Bracco Diagnostics, Inc
Phase
Phase 2
Overall status
Terminated
Start date
July 19, 2018
Completion date
July 31, 2021
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic ductal adenocarcinoma